Why the study?
How do light transmission aggregometry, VerifyNow, and Multiplate compare in detecting clopidogrel resistance and predicting thromboembolic complications in patients undergoing neurovascular stenting?
How do light transmission aggregometry, VerifyNow, and Multiplate compare in detecting clopidogrel resistance and predicting thromboembolic complications in patients undergoing neurovascular stenting?
Different platelet function assays show only modest correlation in detecting clopidogrel resistance, with light transmission aggregometry appearing most accurate for predicting periprocedural thromboembolic complications in neurovascular stenting.
No takes yet. Share an insight, caveat, or question.
LTA may best predict periprocedural risk in neurovascular stenting; leaves open assay standardization and randomized validation.
Flechtenmacher et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: